Navigation Links
2 Scripps Research Institute scientists honored by American Chemical Society
Date:11/9/2012

JUPITER, FL, November 9, 2012 Two chemists from the Florida campus of The Scripps Research Institute (TSRI) have been selected by the American Chemical Society (ACS) to receive a pair of prestigious awards honoring early-career research in biological and enzyme chemistry. Associate Professors Matthew Disney, PhD, and Kate Carroll, PhD, will be recognized at the fall 2013 ACS symposium, to be held in Indianapolis.

Disney has won the Eli Lilly Award in Biological Chemistry, first awarded in 1934. The award is given to a young scientist under the age of 38 for outstanding research in biological chemistry of unusual merit and independence of thought and originality.

"It is a great honor to have been selected to receive this award," Disney said. "I am still in shock because of the quality of the previous winners, many of whom I have looked up to as standard bearers in my field. This award was granted because of the excellent, dedicated work of our team."

Previous winners of the Eli Lilly Award include TSRI faculty members Nobel laureate Gerald Edelman, Peter G. Schultz and Benjamin Cravatt.

One of the major promises of the human genome project has been to identify and exploit disease-associated genes for therapeutic intervention, but these studies are sparse. The Disney group is working to fill this void by designing therapeutics targeting gene products that are disease-associated from only sequence. In initial applications of this approach, the team has developed compounds to target a variety of genetic abnormalities that cause diseases including myotonic dystrophy, Huntington's disease and cancer.

Carroll has received the Pfizer Award in Enzyme Chemistry, established in 1945. The award, given to an individual under 40 who has accomplished outstanding work in enzyme chemistry, is aimed at stimulating fundamental research in enzyme chemistry.

"I am honored to be selected for this award, which also reflects the outstanding efforts of the graduate and postdoctoral researchers who have been associated with my laboratory," Carroll said. "I am extremely fortunate to work with, and learn from, my wonderful colleagues in chemistry and other programs within The Scripps Research Institute."

Previous Pfizer Award winners include TSRI's Frank Huennekens, Paul Schimmel and Gerald Joyce.

The award recognizes Carroll's pioneering work using the tools of chemistry and biology to elucidate protein cysteine oxidation as a new paradigm for the regulation of cell signaling pathways. Her work has important implications for understanding how post-translational modification, the chemical modification of a protein after its synthesis, affects its function. Her team is also leveraging these discoveries to develop new strategies for treating diseases that have a strong oxidative stress component, including cancer and diabetes.


'/>"/>
Contact: Eric Sauter
esauter@scripps.edu
267-337-3859
Scripps Research Institute
Source:Eurekalert  

Related medicine news :

1. Scripps Research scientists show how memory B cells stay in class to fight different infections
2. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
3. Clinical trials start for stroke drug developed by Scripps Research, USC, and ZZ Biotech
4. Scripps Research scientists devise powerful new method for finding therapeutic antibodies
5. Scripps Research Institute scientists show protein linked to hunger also implicated in alcoholism
6. Scripps Research Institute receives $20 million to shed light on HIV drug resistance
7. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
8. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
9. NIH awards $20 million over 5 years to train next generation of global health researchers
10. Researchers develop a new cell and animal model of inflammatory breast cancer
11. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
2 Scripps Research Institute scientists honored by American Chemical Society
(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... HealthCareMandA.com ... —on Thursday, April 20, 2017, at 1:00 PM ET. A recording of the webinar ... the Interactive Webinar Series. , Home health and hospice companies are still popular targets ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one ... cancers and is touted to be the next revolution in our fight against this ... in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , ...
(Date:3/29/2017)... PA (PRWEB) , ... March ... ... eastern suburbs and South Hills of Pittsburgh now have easier access to ... Pennsylvania only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital ...
(Date:3/29/2017)... ... ... The Wharton School of the University of Pennsylvania is pleased to announce that ... gift to establish the Ken Moelis and Julie Taffet Moelis Advance Access Program ... for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions of business ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint ... option for on-premises installation of its Help System for SharePoint was at the farm ... into the entire tenant. , The company recently released a modified version of ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... Policy, Patients Treated at Proton Therapy Centers & Forecast" report to ... The South ... its current market size in 2016. The Untapped Proton Therapy Market for ... Billion USD in 2016. Proton Therapy plays an important ...
(Date:3/29/2017)... , Mar 29, 2017  Providence Medical ... announced the addition of two industry veterans to ... has joined the company to lead Global Marketing, ... leadership.  Together, Mr. Lynch and Mr. Scott have ... Mr. Lynch joins the company with ...
(Date:3/29/2017)...  Zynex (OTCQB: ZYXI), an innovative medical technology company specializing ... for pain management, stroke rehabilitation, cardiac monitoring and neurological ... 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 a.m. ... expects to file its 2016 full year financial results ... ...
Breaking Medicine Technology: